Literature DB >> 17530474

Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia.

Emily Joy Jaehne1, Abdallah Salem, Rodney James Irvine.   

Abstract

RATIONALE: Cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), and para-methoxyamphetamine (PMA) disrupt normal thermoregulation in humans, with PMA being associated with more severe cases of hyperthermia. Harm minimization advice on how to prevent overheating depends on appropriate thermoregulatory behavior by drug users.
OBJECTIVES: The purpose of the current study was to establish dose-response relationships for the effects of a number of commonly used illicit stimulants and investigate the behavioral response to increased core temperature.
MATERIALS AND METHODS: Sprague-Dawley rats with telemetry implants were administered either saline or 4, 12, 26, 40 or 80 micromol/kg of cocaine, methamphetamine, MDMA, or PMA and confined to an ambient temperature of 30 degrees C for 30 min, before being able to choose their preferred temperature on a thermally graded runway (11-41 degrees C).
RESULTS: The increased core temperature caused by administration of cocaine, methamphetamine, and MDMA treatment led to the animals seeking the cool end of the runway to correct their core temperature, although this did not occur in PMA-treated rats. The order of potency for increasing core temperature was methamphetamine >PMA = MDMA>cocaine. This differed to the slopes of the dose-response curves where MDMA and PMA showed the steepest slope for the doses used followed by methamphetamine then cocaine.
CONCLUSIONS: These results suggest that behavioral aspects of thermoregulation are important in assessing the potential of individual drugs to cause harmful increases in core temperature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17530474     DOI: 10.1007/s00213-007-0825-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  56 in total

Review 1.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

2.  Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

Authors:  R de la Torre; M Farré; J Ortuño; M Mas; R Brenneisen; P N Roset; J Segura; J Camí
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

3.  Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.

Authors:  Paul D Callaghan; Kirsten Farrand; Abdallah Salem; Patrick Hughes; Lynette C Daws; Rodney J Irvine
Journal:  Eur J Pharmacol       Date:  2006-07-25       Impact factor: 4.432

4.  Cardiovascular and metabolic responses of hypertensive and normotensive rats to one week of cold exposure.

Authors:  J B Chambers; T D Williams; A Nakamura; R P Henderson; J M Overton; M E Rashotte
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

5.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

6.  A fatal methamphetamine poisoning associated with hyperpyrexia.

Authors:  T Kojima; I Une; M Yashiki; J Noda; K Sakai; K Yamamoto
Journal:  Forensic Sci Int       Date:  1984-01       Impact factor: 2.395

Review 7.  Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.

Authors:  Taizo Kita; George C Wagner; Toshikatsu Nakashima
Journal:  J Pharmacol Sci       Date:  2003-07       Impact factor: 3.337

8.  Cocaine alters body temperature and behavioral thermoregulatory responses.

Authors:  L P Gonzalez
Journal:  Neuroreport       Date:  1993-01       Impact factor: 1.837

9.  Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.

Authors:  J F Nash; H Y Meltzer; G A Gudelsky
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

Review 10.  The health effects of ecstasy: a literature review.

Authors:  Linda R Gowing; Susan M Henry-Edwards; Rodney J Irvine; Robert L Ali
Journal:  Drug Alcohol Rev       Date:  2002-03
View more
  7 in total

1.  Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage.

Authors:  Ana B Sanchez; Giuseppe P Varano; Cyrus M de Rozieres; Ricky Maung; Irene C Catalan; Cari C Dowling; Natalia E Sejbuk; Melanie M Hoefer; Marcus Kaul
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

Review 2.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes.

Authors:  Emily Joy Jaehne; Abdallah Salem; Rodney James Irvine
Journal:  Psychopharmacology (Berl)       Date:  2008-08-06       Impact factor: 4.530

Review 4.  Management of the critically poisoned patient.

Authors:  Jennifer S Boyle; Laura K Bechtel; Christopher P Holstege
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-06-29       Impact factor: 2.953

5.  MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.

Authors:  P Sáez-Briones; A Hernández
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363

Review 6.  Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND.

Authors:  Ana B Sanchez; Marcus Kaul
Journal:  Brain Sci       Date:  2017-02-23

7.  Intramuscular Route of Administration Increases Potency in Eliciting Cocaine-Induced Behavioral Sensitization.

Authors:  Beth Ann Rice; Raza Tariq; Chana K Akins
Journal:  Curr Psychopharmacol       Date:  2017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.